Episode 6: Medicare GLP 1 Coverage: What Older Adults Need to Know About Wegovy, Zepbound & Obesity Care

Medicare, GLP 1s, and Fear: What Older Adults Need to Know | Angela Fitch, MD, Tracy Zvenyach, PhD, MS, RN, and Deb Cooperman

As Medicare coverage for obesity treatment continues to evolve, many older adults are asking the same questions:

Can Medicare cover GLP 1 medications like Wegovy or Zepbound? Who qualifies for the Medicare Bridge Program? What should adults over 65 know before starting obesity treatment?

In this episode of Weight & Measure with Mike and Zach, we explore the rapidly changing landscape of obesity medicine, Medicare access, and GLP 1 treatment for older adults.

Joining us are nationally recognized obesity medicine physician Angela Fitch, MD, obesity policy expert Tracy Zvenyach, PhD, MS, RN, and patient advocate Deb Cooperman to discuss what seniors, caregivers, and healthcare professionals need to know about starting GLP 1 medications later in life.

Topics discussed include:

• Medicare coverage for GLP 1 medications
• The Medicare Bridge Program and who may qualify
• Wegovy, Zepbound, Mounjaro, and other obesity medications
• Obesity treatment after age 65
• Weight loss, muscle loss, and body composition in older adults
• Nutrition strategies while taking GLP 1 medications
• Side effects and medication expectations
• Mobility, strength, and healthy aging
• Caregiver and family support during treatment
• Access, affordability, and obesity care policy
• Bariatric and metabolic surgery considerations
• Long-term obesity management and maintenance

Whether you are considering Wegovy, Zepbound, Mounjaro, or another obesity treatment, this episode provides evidence-informed insights to help older adults make informed decisions alongside their healthcare team.

Resources:

• CMS Medicare Bridge Program Information: https://www.cms.gov/glp-1-bridge.pdf

Weight & Measure with Mike and Zach is a podcast and live video series bringing together patients, clinicians, researchers, advocates, and policymakers to discuss obesity medicine, GLP 1 medications, Bariatric & Metabolic Surgery, weight management, access to care, and metabolic health.

Subscribe for future conversations covering obesity treatment, Medicare policy, weight loss medications, metabolic health, patient advocacy, and evidence-based obesity care.

Keywords: Medicare GLP 1 coverage, Medicare Bridge Program, Wegovy Medicare, Zepbound Medicare, Mounjaro Medicare, obesity medicine, obesity treatment for seniors, weight loss after 65, obesity care, metabolic health, obesity advocacy, Angela Fitch, Tracy Zvenyach, Deb Cooperman, Weight & Measure podcast.